OUR SERVICES
Pneumonia is the leading cause of childhood death in the world. Among bacteria that cause pneumonia are organisms such as Streptococcus pneumoniae and gram negative bacteria that belong to the Enterobacteriaceae family.
MDR Therapeutics has developed a platform-based vaccine technology that elicits first in class bacterial specific mucosal immune responses including both T cell and B cell responses. Thus, this technology provides dual levels of protection against pneumonia. Importantly our vaccine technology does not rely on older technology that uses polysaccharide capsule as an antigen in which bacteria can escape. MDR uses components of the outer membranes of bacteria and thus this platform can elicit serotype independent protection against pneumonia. Moreover MDR is developing needleless vaccine technology so vaccines can be deployed and administered around the globe.
MDR Therapeutics has developed a platform-based vaccine technology that elicits first in class bacterial specific mucosal immune responses including both T cell and B cell responses. Thus, this technology provides dual levels of protection against pneumonia. Importantly our vaccine technology does not rely on older technology that uses polysaccharide capsule as an antigen in which bacteria can escape. MDR uses components of the outer membranes of bacteria and thus this platform can elicit serotype independent protection against pneumonia. Moreover MDR is developing needleless vaccine technology so vaccines can be deployed and administered around the globe.
